A 12-year follow-up study of combined treatment of post-severe acute respiratory syndrome patients with femoral head necrosis | Canada Hyperbarics Skip to main content
Retrospective Study Ther Clin Risk Manag 2017

A 12-year follow-up study of combined treatment of post-severe acute respiratory syndrome patients with femoral head necrosis

Liu T, Ma J, Su B, Wang H, Wang Q, Ma X — Ther Clin Risk Manag, 2017

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers looked back at 37 patients (66 hip joints) who developed femoral head necrosis after having SARS, to see how well a combined treatment of alendronate, extracorporeal shock, and hyperbaric oxygen worked over 12 years.

What They Found

After 12 years, patients showed significant improvement in pain, with average VAS scores dropping from 6.81 before treatment to 3.94. Their hip function, measured by the Harris score, also improved from 74.54 to 80.14. The combined treatment was most effective for patients in the early stages (ARCO Phase I) of femoral head necrosis.

What This Means for Canadian Patients

For Canadian patients who developed femoral head necrosis after SARS, this study suggests that a combined treatment including hyperbaric oxygen therapy might help slow down or stop the progression of the condition. This could potentially reduce pain and improve hip function over many years.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a retrospective study with a relatively small number of patients and no control group, these findings need to be confirmed by larger, more controlled research.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Uncategorised
Source Pubmed
PubMed ID 29089773
Year Published 2017
Journal Ther Clin Risk Manag

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.